by The global biodegradable scaffold market provides a natural substitute for non-biodegradable synthetic scaffold materials commonly used for applications in tissue engineering and regeneration. Biodegradable scaffold material offers advantages like better integration with surrounding tissues, degradation as tissue grows, controllable biomechanical properties and minimum adverse tissue response. The increasing applications of biodegradable scaffold in wound healing and skin regeneration is driving the market growth.
The global biodegradable scaffold market is estimated to be valued at US$ 2.31 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
Growing applications in wound healing is one of the key trends fueling growth of the biodegradable scaffold market. Biodegradable scaffold materials are extensively used in skin regeneration and healing of chronic and acute wounds as they mimic the composition and structure of the extracellular matrix in skin tissues. They aid in re-epithelialization of skin by providing a favorable microenvironment for cell growth and vascularization. Research has shown that biodegradable scaffolds containing extracellular matrix proteins, growth factors and cells can effectively regenerate full-thickness skin and accelerate wound healing. The increasing research on exploration of advanced biodegradable scaffold materials and technologies for wound healing and skin regeneration applications is expected to present lucrative opportunities over the forecast period.
SWOT Analysis
Strength: Biodegradable scaffolds are absorbable by the body and pose no long-term side effects. They provide structural support for tissue regrowth.
Weakness: The degradation rate and mechanical integrity need to match the rate of tissue regeneration for optimal results, which is still a challenge. Production processes are complex.
Opportunity: Rising prevalence of chronic diseases and injuries drive the need for tissue engineering solutions. 3D printing and advanced material technology help meet customization needs.
Threats: Stringent regulations and long product approval times hamper market access. High R&D costs and product pricing pressures exist.
Key Takeaways
The global Biodegradable Scaffold Market Share is expected to witness high growth over the forecast period of 2024 to 2031. The global biodegradable scaffold market is estimated to be valued at US$ 2.31 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031.
Regional analysis
The North American region holds the major share in the global biodegradable scaffold market due to heavy investments in tissue engineering research and presence of key market players. Europe is the second largest regional market supported by increasing funding for clinical trials evaluating tissue engineering applications. Asia Pacific is expected to grow at the fastest pace with rising medical tourism and healthcare spending in countries like China and India.
Key players
Key players operating in the biodegradable scaffold market include Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva, and Nordson MEDICAL. These players are focusing on new product development and geographical expansion to increase their market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
